New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Author Names

BACKGROUND: Chronic hepatitis C (HCV) is a difficult to treat disease affecting over 3 million Americans. Protease inhibitors increase the effectiveness of standard therapy but are costly. A genetic assay may identify patients most likely to benefit from this treatment advance. OBJECTIVE: Cost-effec...

Full description

Saved in:
Bibliographic Details
Main Authors: Liu, Shan, Cipriano, Lauren E., Holodniy, Mark, Owens, Douglas K., Goldhaber-Fiebert, Jeremy D.
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586733/
https://ncbi.nlm.nih.gov/pubmed/22351713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1059/0003-4819-156-4-201202210-00005
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items